CSS
XERS icon

Cubist Systematic Strategies’s Xeris Biopharma Holdings XERS Stock Holding History

Cubist Systematic Strategies’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-880,314
Closed -$4.11M – 3640
2025
Q2 		$4.11M Buy
880,314
+68,707
+8% +$315K 0.02% 1138
2025
Q1 		$4.46M Buy
+811,607
New +$3.28M 0.03% 952
2023
Q4 		– Sell
-95
Closed -$177 – 4182
2023
Q3 		$177 Sell
95
-15,009
-99% -$34.4K ﹤0.01% 3245
2023
Q2 		$39.6K Buy
+15,104
New +$38.5K ﹤0.01% 3121
2023
Q1 		– Sell
-7,968
Closed -$10.6K – 4493
2022
Q4 		$10.6K Sell
7,968
-6,678
-46% -$9.43K ﹤0.01% 4040
2022
Q3 		$23K Sell
14,646
-1,310
-8% -$2.17K ﹤0.01% 4228
2022
Q2 		$25K Sell
15,956
-199,290
-93% -$421K ﹤0.01% 4191
2022
Q1 		$551K Sell
215,246
-96,551
-31% -$236K ﹤0.01% 2478
2021
Q4 		$914K Buy
311,797
+294,251
+1,677% +$636K 0.01% 1982
2021
Q3 		$43K Sell
17,546
-29,684
-63% -$86.2K ﹤0.01% 2847
2021
Q2 		$192K Sell
47,230
-13,785
-23% -$52.6K ﹤0.01% 2579
2021
Q1 		$275K Buy
61,015
+15,618
+34% +$84.2K ﹤0.01% 2313
2020
Q4 		$223K Buy
+45,397
New +$227K ﹤0.01% 2186
2019
Q2 		– Sell
-25,693
Closed -$258K – 2601
2019
Q1 		$258K Buy
+25,693
New +$329K 0.01% 1608
2018
Q3 		– Sell
-645
Closed -$12K – 2110
2018
Q2 		$12K Buy
+645
New +$12.5K ﹤0.01% 1716

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Cubist Systematic Strategies's XERS Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Xeris Biopharma Holdings (XERS) in Q3 2025, closing a stake of 880,314 shares — an estimated $4.11M sold.

Cubist Systematic Strategies first reported a position in XERS in Q2 2018 and held it in 15 quarters. The position peaked at $4.46M in Q1 2025. 230 funds tracked by Wall St. Rank hold XERS as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Xeris Biopharma Holdings position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 880,314 Xeris Biopharma Holdings shares in Q3 2025, an estimated $4.11M.
  • Cubist Systematic Strategies first reported a position in Xeris Biopharma Holdings in Q2 2018 and held it in 15 quarters.
  • Cubist Systematic Strategies's Xeris Biopharma Holdings position peaked at $4.46M in Q1 2025.
  • 230 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.